Abstract
Cytokines play a key role in modulation of immune responses. Cytokine networks regulate lymphocyte turnover, differentiation, and activation. Many different cell types, in addition to immune cells, produce cytokines and express receptors for cytokines. Cell-to-cell communication (cellular “crosstalk”) is maintained via cytokine networks. In disease, these networks undergo imbalance. By measuring amplification or downregulation of cytokine signaling cascades in response to pathological insults or therapeutic interventions, it might be possible to evaluate disease progression or regression. Multiplex formats for cytokine profiling are now available and appear to be especially useful in monitoring cytokine profile alterations in a variety of human diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vilcek J. The cytokines: an overview. In: Thomson AW, Lotze MT, eds. The Cytokine Handbook. 4th ed, Boston, Academic Press, 2003, pp. 3–18.
Zlotnik A, Osamu Y. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12:121–127.
Dinarello CA, Kluger MJ, Powanda MC. The Physiologicalal and Pathologicalal Effects of Cytokines. New York: Liss; 1990.
Oppenheim JJ. Clinical Applications of Cytokines. Role in Pathogenesis, Diagnosis and Therapy. New York: Oxford University Press; 1993.
Aggarwal BB, Puri RK, eds. Human Cytokines: Their Role in Disease and Therapy. Cambridge, MA: Blackwell Science; 1995.
Meager T. The Molecule Biology of Cytokines. Chichester: John Wiley & Sons; 1998.
Taniguchi T, Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell 1993;11:245–267.
Smith KA. Interleukin-2: inception, impact, and implications. Science 1988;240:1169–1176.
Hatakeyama M, Tsudo M, Minamoto S, et al. Interleukin-2 receptor β chain gene: generation of three receptor forms by cloned human a and β chain cDNAs. Science 1989;244:551–556.
Lowenthal JW, Ballard DW, Bogerd H, Bohnlein E, Greene WC. Tumor necrosis factor-a activation of the IL-2 receptor-a gene involves the induction of kB-specific DNA binding proteins. J Immunol 1989;142:3121–3128.
Aggarwal BB, Eessalu TE, Hass PE. Characterization of receptors for human tumour necrosis factor and their regulation by y-interferon. Nature 1985;318: 665–667.
Dinarello CA, Wolff SM. Mechanisms of disease: the role of interleukin 1 in disease. N Engl J Med 1993;328:106–113.
Romagnani, S. The Th1/Th2 paradigm. Immunol Today 1997;18:263–266.
Romagnani, S. The Th1/Th2 Paradigm in Disease. Austin: R.G. Landes Co.; 1997.
Mosmann TR, Li L, Sad S. Functions of CD8 T-cell subsets secreting different cytokine patterns. Semin Immunol 1997;9:87–92.
Sorensen TT, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318:727–732.
Westendorp RG, Langermans JA, Huizinga TW, Verweij CL, Sturk A. Genetic influence on cytokine production in meningococcal disease. Lancet 1997;349:1912–1913.
van Dissel JT, van Langevelde P, Westendorp RG, et al. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998;351:950–953.
Gallagher G, Eskdale J, Bidwell JL. Cytokine genetics — polymorphisms, functional variations and disease associations. In: Thomson AW, Lotze MT, eds. The Cytokine Handbook, 4th ed. Boston: Academic Press; 2003, pp. 19–55.
Langer JA, Pestka S. Interferon receptors. Immunol Today 1989; 12:393–400.
Whiteside TL. Assays for Ccytokines. In: Thomson AW, Lotze MT, eds. The Cytokine Handbook, 4th ed. Boston: Academic Press; 2003, pp. 1375–1396.
De Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. CDLI 2003;10:133–139.
Whiteside TL. Cytokine assays. Biotechniques/Cytokines 2002;33:4–15.
Mathey E, Pollard J, Armati P. In situ hybridization for cytokines in human tissue biopsies. Methods Mol Biol 2003; 204:57–66.
Kjellstrom S, Appels N, Ohlrogge M, Laurell T, Marko-Varga G. Microdialysis—a membrane based sampling technique for quantitative determination of proteins. J Chromatogr A 1999;50:539–546.
Tatsumi T, Kierstead LS, Ranieri E, et al. Disease-associated bias in T helper type 1 (Th1)/Th2 CD4+ T-cell responses against MAGE-6 in HLA-DRB1*0401+ patients with renal cell carcinoma or melanoma. J Exp Med 2002; 196:619–628.
Nicholas J, Ruvolo VR, Burns WH, et al. Kaposi’s sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 1997;3:287–292.
Connor RI, Sheridan KE, Ceradini D, Choe S, Landau N. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med 1997; 185:621–628.
Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infections, neoplastic and inflammatory diseases. Clin Microbiol Rev 1996;9:532–562.
Grewe M, Bruijnzeel-Koomen CA, Schopf E, et al. A role for Th1 and Th2 cells in the immunopatheogenesis of atopic dermatitis. Immunol Today 1998;19:539–661.
Lew W, Bowcock AM, Krueger JG. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and “Type 1” inflammatory gene expression. Trends Immunol 2004;25:295–305.
O’Shea JJ, Ma A, Lipsky P. Cytokines and autoimmunity. Nat Rev Immunol 2002;2:37–45.
Surh CD, Sprent J. Regulation of naive and memory T cell homeostasis. Microbes Infect 2000;4:51–56.
Khaled A, Durum SK. The role of cytokines in lymphocyte homeostasis. Biotechniques 2002;33:540–545.
Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin-and down-regulated by tumor nicrosis factor alpha. J Exp Med 1994; 179:1109–1118.
Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev 2003;3:269–279.
Kishimoto T. Factors affecting B cell growth and differentiation. Annu Rev Immunol 1985;3:133–157.
Biron C. Activation of natural killer cell responses during viral infections. Curr Opin Immunol 1997;9:24–34.
Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2001;2:123–128.
Haddad JJ, Saade NE, Safieh-Garabedian B. Cytokines and neuro-immuneendocrine interactions: a role for the hypothalamicpituitaryadrenal revolving axis. J Neuroimmunol 2002; 133:1–19.
Calandra T, Bucala R. Macrophage migration inhibition factors MIF: a glucocorticoid counter regulator within the immune system. Crit Rev Immunol 1997;17:77–88.
Straub RH, Westermann J, Scholmerich J, Falk W. Dialogue between the CNS and the immune system in lymphoid organs. Immunol Today 1998; 19:409–413.
Foon KA, Maluish AE, Abrams PG, et al. Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia: therapeutic and immunological results. Am J Med 1986;80:351–356.
Baluna R, Vitetta ES. Vascular leak syndrome: a side effect of immunotherapy. Immunopharmacology 1997;37:117–132.
Rosenberg SA, Lotze MT, Yang JC, et al. Experience with the use of high dose interleukin-2 in the treatment of 652 cancer patients. Ann Surg 1989;210:474–485.
Kirkwood JM, Richards T, Zarour HM, et al. Immunomodulatory effects of high-dose and low-dose interferon a2b in patients with high-risk resected melanoma. Cancer 2002;95:1101–1112.
Whiteside TL, Letessier E, Hirabayashi H, et al. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck. Cancer Res 1993;53:5654–5662.
Pardoll DM. Paracrine cytokine adjuvants in cancer immunotherapy. Annu Rev Immunol 1995; 13:399–415.
Meneses A, Verastegui E, Barrera JL, DeGarz J, Hadden JW. Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2. Int Immunopharmacol 2003;3:1083–1091.
Gillies SD, Lan Y, Brunkhorst B, Wong WK, Li Y, Lo KM. Bifunctional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer. Cancer Immunol Immunother 2002;51:449–460.
Lode HN, Xiang R, Becker JC, Gillies SD, Reisfeld RA. Immunocytokines: a promising approach to cancer immunotherapy. Pharmacol Ther 1998;80:277–292.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Whiteside, T.L. (2007). Introduction to Cytokines as Targets for Immunomodulation. In: House, R.V., Descotes, J. (eds) Cytokines in Human Health. Methods in Pharmacology and Toxicology. Humana Press. https://doi.org/10.1007/978-1-59745-350-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-59745-350-9_1
Publisher Name: Humana Press
Print ISBN: 978-1-58829-467-8
Online ISBN: 978-1-59745-350-9
eBook Packages: Springer Protocols